Form 10-Q - Quarterly report [Sections 13 or 15(d)]:
SEC Accession No. 0001096906-12-001533
Filing Date
2012-05-21
Accepted
2012-05-21 11:47:38
Documents
9
Period of Report
2012-03-31

Document Format Files

Seq Description Document Type Size
1 SIGNPATH PHARMA, INC. FORM 10-Q MARCH 31, 2012 signpath10q20120331.htm 10-Q 721663
2 CERTIFICATION OF THE CHIEF EXECUTIVE OFFICER AND CHIEF FINANCIAL OFFICER PURSUAN ex31-1.htm EX-31.1 15408
3 CERTIFICATION OF THE CHIEF EXECUTIVE OFFICER AND CHIEF FINANCIAL OFFICER PURSUAN ex32-1.htm EX-32.1 9096
  Complete submission text file 0001096906-12-001533.txt   2503985

Data Files

Seq Description Document Type Size
4 XBRL INSTANCE sppxbrl-20120331.xml EX-101.INS 377240
5 XBRL SCHEMA sppxbrl-20120331.xsd EX-101.SCH 11238
6 XBRL CALCULATION sppxbrl-20120331_cal.xml EX-101.CAL 6467
7 XBRL DEFINITION sppxbrl-20120331_def.xml EX-101.DEF 42104
8 XBRL LABEL sppxbrl-20120331_lab.xml EX-101.LAB 78189
9 XBRL PRESENTATION sppxbrl-20120331_pre.xml EX-101.PRE 57587
Mailing Address 1375 CALIFORNIA ROAD QUAKERTOWN PA 18951
Business Address 1375 CALIFORNIA ROAD QUAKERTOWN PA 18951 267-772-0107
SignPath Pharma, Inc. (Filer) CIK: 0001455694 (see all company filings)

EIN.: 205079533 | State of Incorp.: DE | Fiscal Year End: 1231
Type: 10-Q | Act: 34 | File No.: 333-158474 | Film No.: 12857467
SIC: 2834 Pharmaceutical Preparations